Revenue
2022
2023
2024
2025
innoscripta SE (1INN)
Price€81.40Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | €103.4M | €64.7M | €39.4M | €27.3M |
| Gross profit | €99.3M | €62.9M | €38.1M | €26.6M |
| Gross margin | 96.02% | 97.20% | 96.70% | 97.54% |
| Operating expenses | €35.9M | €25.6M | €22.6M | €17.4M |
| Operating income | €63.4M | €37.3M | €15.5M | €9.2M |
| Operating margin | 61.33% | 57.61% | 39.29% | 33.66% |
| EBITDA | €63.8M | €37.7M | €15.7M | €9.5M |
| EBITDA margin | 61.73% | 58.24% | 39.83% | 34.67% |
| Net income | €42.6M | €25.1M | €10.3M | €6.1M |
| Net profit margin | 41.20% | 38.77% | 26.09% | 22.37% |
| Basic EPSper basic share | €4.26 | €2.51 | €1.03 | €0.61 |
| Diluted EPSper diluted share | €4.26 | €2.51 | €1.03 | €0.61 |